COMPUGROUP MEDICAL SE & CO K (COP.DE) Stock Fundamental Analysis
FRA:COP - Deutsche Boerse Ag - DE000A288904 - Common Stock - Currency: EUR
Taking everything into account, COP scores 3 out of 10 in our fundamental rating. COP was compared to 12 industry peers in the Health Care Technology industry. COP has a medium profitability rating, but doesn't score so well on its financial health evaluation. COP is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year COP was profitable.
COP had a positive operating cash flow in the past year.
In the past 5 years COP has always been profitable.
Each year in the past 5 years COP had a positive operating cash flow.
1.2 Ratios
The Return On Assets of COP (1.30%) is comparable to the rest of the industry.
COP has a Return On Equity (3.97%) which is in line with its industry peers.
With a Return On Invested Capital value of 3.68%, COP perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
COP had an Average Return On Invested Capital over the past 3 years of 4.69%. This is below the industry average of 7.76%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.3% | ||
| ROE | 3.97% | ||
| ROIC | 3.68% |
ROA(3y)3.35%
ROA(5y)4.18%
ROE(3y)9.69%
ROE(5y)13.19%
ROIC(3y)4.69%
ROIC(5y)5.95%
1.3 Margins
COP has a Profit Margin (2.18%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of COP has declined.
COP has a Operating Margin of 7.48%. This is in the better half of the industry: COP outperforms 63.64% of its industry peers.
In the last couple of years the Operating Margin of COP has declined.
COP has a worse Gross Margin (33.03%) than 72.73% of its industry peers.
In the last couple of years the Gross Margin of COP has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.48% | ||
| PM (TTM) | 2.18% | ||
| GM | 33.03% |
OM growth 3Y-13.21%
OM growth 5Y-14.58%
PM growth 3Y-23.81%
PM growth 5Y-22.01%
GM growth 3Y-4.53%
GM growth 5Y-3.73%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COP is destroying value.
The number of shares outstanding for COP remains at a similar level compared to 1 year ago.
The number of shares outstanding for COP has been increased compared to 5 years ago.
Compared to 1 year ago, COP has about the same debt to assets ratio.
2.2 Solvency
COP has an Altman-Z score of 1.82. This is not the best score and indicates that COP is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.82, COP is in line with its industry, outperforming 45.45% of the companies in the same industry.
The Debt to FCF ratio of COP is 11.01, which is on the high side as it means it would take COP, 11.01 years of fcf income to pay off all of its debts.
COP has a Debt to FCF ratio (11.01) which is comparable to the rest of the industry.
COP has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
COP's Debt to Equity ratio of 1.22 is on the low side compared to the rest of the industry. COP is outperformed by 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | 11.01 | ||
| Altman-Z | 1.82 |
ROIC/WACC0.73
WACC5.07%
2.3 Liquidity
COP has a Current Ratio of 1.03. This is a normal value and indicates that COP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of COP (1.03) is worse than 72.73% of its industry peers.
A Quick Ratio of 0.98 indicates that COP may have some problems paying its short term obligations.
COP's Quick ratio of 0.98 is on the low side compared to the rest of the industry. COP is outperformed by 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
The earnings per share for COP have decreased strongly by -66.96% in the last year.
COP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.83% yearly.
The Revenue has decreased by -4.65% in the past year.
COP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.62% yearly.
EPS 1Y (TTM)-66.96%
EPS 3Y-13.7%
EPS 5Y-14.83%
EPS Q2Q%-46.14%
Revenue 1Y (TTM)-4.65%
Revenue growth 3Y12.36%
Revenue growth 5Y10.62%
Sales Q2Q%-0.8%
3.2 Future
COP is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.67% yearly.
The Revenue is expected to grow by 1.57% on average over the next years.
EPS Next Y-26.11%
EPS Next 2Y-13.45%
EPS Next 3Y-6.67%
EPS Next 5YN/A
Revenue Next Year-2.33%
Revenue Next 2Y0.12%
Revenue Next 3Y1.1%
Revenue Next 5Y1.57%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 47.75 indicates a quite expensive valuation of COP.
The rest of the industry has a similar Price/Earnings ratio as COP.
The average S&P500 Price/Earnings ratio is at 28.47. COP is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 13.87, the valuation of COP can be described as correct.
Based on the Price/Forward Earnings ratio, COP is valued cheaper than 81.82% of the companies in the same industry.
COP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.74.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.75 | ||
| Fwd PE | 13.87 |
4.2 Price Multiples
COP's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, COP is valued a bit cheaper than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.92 | ||
| EV/EBITDA | 9.72 |
4.3 Compensation for Growth
A cheap valuation may be justified as COP's earnings are expected to decrease with -6.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.45%
EPS Next 3Y-6.67%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.30%, COP is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.80, COP pays a better dividend. On top of this COP pays more dividend than 81.82% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, COP pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.3% |
5.2 History
The dividend of COP is nicely growing with an annual growth rate of 7.28%!
Dividend Growth(5Y)7.28%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
COP pays out 205.57% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of COP has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP205.57%
EPS Next 2Y-13.45%
EPS Next 3Y-6.67%
COMPUGROUP MEDICAL SE & CO K
FRA:COP (2/5/2025, 10:36:20 AM)
22.92
+0.08 (+0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners24.56%
Inst Owner ChangeN/A
Ins Owners50.36%
Ins Owner ChangeN/A
Market Cap1.23B
Analysts72.94
Price Target25.87 (12.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.3% |
Yearly Dividend0.5
Dividend Growth(5Y)7.28%
DP205.57%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.96%
PT rev (3m)-4.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.68%
EPS NY rev (3m)2.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)-0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.75 | ||
| Fwd PE | 13.87 | ||
| P/S | 1.07 | ||
| P/FCF | 15.92 | ||
| P/OCF | 8.35 | ||
| P/B | 1.94 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.72 |
EPS(TTM)0.48
EY2.09%
EPS(NY)1.65
Fwd EY7.21%
FCF(TTM)1.44
FCFY6.28%
OCF(TTM)2.75
OCFY11.98%
SpS21.44
BVpS11.8
TBVpS-13.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.3% | ||
| ROE | 3.97% | ||
| ROCE | 5.49% | ||
| ROIC | 3.68% | ||
| ROICexc | 3.88% | ||
| ROICexgc | 39.78% | ||
| OM | 7.48% | ||
| PM (TTM) | 2.18% | ||
| GM | 33.03% | ||
| FCFM | 6.71% |
ROA(3y)3.35%
ROA(5y)4.18%
ROE(3y)9.69%
ROE(5y)13.19%
ROIC(3y)4.69%
ROIC(5y)5.95%
ROICexc(3y)5%
ROICexc(5y)6.32%
ROICexgc(3y)57.88%
ROICexgc(5y)61.98%
ROCE(3y)7.01%
ROCE(5y)8.91%
ROICexcg growth 3Y-15.48%
ROICexcg growth 5Y-14.57%
ROICexc growth 3Y-9.12%
ROICexc growth 5Y-20.09%
OM growth 3Y-13.21%
OM growth 5Y-14.58%
PM growth 3Y-23.81%
PM growth 5Y-22.01%
GM growth 3Y-4.53%
GM growth 5Y-3.73%
F-Score4
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | 11.01 | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 59.04% | ||
| Cap/Sales | 6.09% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.95% | ||
| Profit Quality | 307.33% | ||
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 1.82 |
F-Score4
WACC5.07%
ROIC/WACC0.73
Cap/Depr(3y)63.72%
Cap/Depr(5y)66.87%
Cap/Sales(3y)6.48%
Cap/Sales(5y)6.39%
Profit Quality(3y)157.58%
Profit Quality(5y)140.57%
High Growth Momentum
Growth
EPS 1Y (TTM)-66.96%
EPS 3Y-13.7%
EPS 5Y-14.83%
EPS Q2Q%-46.14%
EPS Next Y-26.11%
EPS Next 2Y-13.45%
EPS Next 3Y-6.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.65%
Revenue growth 3Y12.36%
Revenue growth 5Y10.62%
Sales Q2Q%-0.8%
Revenue Next Year-2.33%
Revenue Next 2Y0.12%
Revenue Next 3Y1.1%
Revenue Next 5Y1.57%
EBIT growth 1Y-43.05%
EBIT growth 3Y-2.48%
EBIT growth 5Y-5.51%
EBIT Next Year34.68%
EBIT Next 3Y15.14%
EBIT Next 5Y9.93%
FCF growth 1Y72.47%
FCF growth 3Y5.84%
FCF growth 5Y3.07%
OCF growth 1Y20.85%
OCF growth 3Y6.19%
OCF growth 5Y5.66%